Xia, X.; Wu, M.; Gao, Q.; Sun, X.; Ge, X.
Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy. Curr. Oncol. 2022, 29, 6342-6349.
https://doi.org/10.3390/curroncol29090499
AMA Style
Xia X, Wu M, Gao Q, Sun X, Ge X.
Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy. Current Oncology. 2022; 29(9):6342-6349.
https://doi.org/10.3390/curroncol29090499
Chicago/Turabian Style
Xia, Xiaojie, Mengxing Wu, Qing Gao, Xinchen Sun, and Xiaolin Ge.
2022. "Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy" Current Oncology 29, no. 9: 6342-6349.
https://doi.org/10.3390/curroncol29090499
APA Style
Xia, X., Wu, M., Gao, Q., Sun, X., & Ge, X.
(2022). Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy. Current Oncology, 29(9), 6342-6349.
https://doi.org/10.3390/curroncol29090499